Improving Cancer Outcomes for African Americans Update for RTOG in Tampa Feb 2, 2007 Patrick D. Maguire, MD New Hanover Regional (NHRMC)

Slides:

Advertisements

Similar presentations

AACI 2008 State Funding for Cancer Centers Shelton Earp, MD.

Advertisements

Update on Ovarian Cancer

Minorities and the medically underserved in clinical trials Edward L. Trimble, MD, MPH CTEP, DCTD, NCI.

Pulmonary Stereotactic Ablative Radiotherapy:

Please note, these are the actual video-recorded proceedings from the live CME event and may include the use of trade names and other raw, unedited content.

Danny Indelicato, MD CTOS 2012 Ewing Sarcoma of the Axial Skeleton: Early Outcomes from the University of Florida Proton Therapy Program.

Dwight E. Heron, MD (on behalf of the Cancer Disparities Research Partnership) ASTRO Education Symposium November 6 th, 2006.

Delivering care to the underserved: Increasing the Numbers of Minority Physicians Ruben Gonzalez MD CCRMC.

MMC Cancer Institute Navigation Program Donna Green BSN, RN,BA,OCN

Unequal Treatment: Confronting Racial and Ethnic Disparities in Healthcare Institute of Medicine.

Controversies in Adjuvant Therapy for Pancreatic Cancer Parag Sanghvi M.D. Tasha McDonald M.D. Department of Radiation Medicine OHSU.

Child Health Disparities Denice Cora-Bramble, MD, MBA Professor of Pediatrics, George Washington University Executive Director Goldberg Center for Community.

Cancer Disparities Research Partnership Program Process & Outcome Evaluation Amanda Greene, PhD, MPH, RN Paul Young, MBA, MPH Natalie Stultz, MS NOVA Research.

Postoperative Radiation for Oral Cavity Squamous Cell Carcinoma: The EP.

What Dose is optimal ? Locally Advanced NSCLC… Dr P Vijay Anand Reddy Director Apollo Cancer Institute, Hyd.

MS/AL Radiation Oncology Research Partnership W. Sam Dennis, MD, PhD P.I., Singing River Hospital System Sharon Spencer, MD P.I., University of Alabama.

Driving the Transition to Individualized Cancer Treatment by Addressing Critical Questions 1 Do I need surgery? chemotherapy? radiation? INVASIVE BREAST.

New York University Department of Radiation Oncology A Phase I-II Study of Adjuvant Concurrent Carboplatin and Accelerated Radiotherapy for Triple Negative.

Dr. Rico Liu Consultant, Department of Clinical Oncology, Queen Mary Hospital Honorary Clinical Associate Professor, Department of Clinical Oncology, The.

IMRT for the Treatment of Anal Cancer Kristen O’Donnell, MS3 December 12, 2007.

January 11 th, 2012: Opening Remarks: Thomas Farrington, PHEN President & Founder & Jacques Carter, MD, Dana Farber Cancer Institute Featured Speaker:

1 Non–Small-Cell Lung Cancer Diagnosis and Staging EvaluationPurpose Physical examinationIdentify signs Chest x-rayDetermine position, size, number of.

Open to Options: Training Cancer Research Staff to Enhance Clinical Trials Access Margo Michaels, Natasha Blakeney, Melissa Miller, Kathleen Coyne, Bonnie.

Clinical Trials that Address Health Care Disparities Daniel G. Petereit, MD Department of Radiation Oncology University of Wisconsin Medical School University.

Low Health Literacy Poor Relationships with Providers Historical Racism in Medical Care Socioeconomic Status Insurance Coverage Religious Beliefs Poor.

A Phase II Study to Evaluate the Safety and Toxicity of Sparing Radiation to the Pathologic N0 Side of the Neck in Squamous Cell.

Connecting South Carolina: The Gibbs/Hollings Cancer Center An NCCCP/NCI Designated Center Connection Anita L. Harrison, MPH Associate Director, Administration.

Clinico-Dosimetric Correlation for Acute and Chronic Gastrointestinal Toxicity in Patients of Locally Advanced Carcinoma Cervix Treated With Conventional.

Urban Latino African American Cancer (ULAAC) Disparities Project at Centinela Freeman Regional Medical Center Michael L. Steinberg, MD, FACR Principal.

Postoperative Radiotherapy for Patients with Stage II or III Nonsmall Cell Lung Cancer treated with Sublobar Resections: A SEER Registry Analysis Scott.

Prospective Phase I/II Trial of Carbon Ion Radiotherapy for Locally Advanced Non-small-cell Lung Cancer (NSCLC) Abstract title: CIRT for Locally Advanced.

Prostate Cancer Screening in African American Men Mark H. Kawachi, MD FACS Director, Prostate Cancer Center City of Hope, National Medical Ctr.

Radiation Therapy in the Management of Cervical Carcinoma Patrick S Swift, MD Medical Director, Radiation Oncology Alta Bates Comprehensive Cancer Center.

Recent Advances in Head and Neck Cancer Robert I. Haddad, M.D., and Dong M. Shin, M.D. The NEW ENGLAND JOURNAL of MEDICINE N Engl J Med 2008;359:

PROSTATE CANCER: RADIATION THERAPY APPROACHES ANDREW L. SALNER, MD FACR DIRECTOR HELEN & HARRY GRAY CANCER CENTER HARTFORD HOSPITAL, CT.

Gibbs Regional Medical Center Spartanburg Regional Healthcare System, Spartanburg, SC.

Robert Dreicer, M.D., M.S., FACP Chair Dept of Solid Tumor Oncology

Cancer Disparities Research Partnership (CDRP): Linking University & Community Radiation Oncology to Improve Cancer Outcomes Patrick D. Maguire, M.D. New.

Comparison of SIB-IMRT and Conventional Accelerated Hyper-fractionated IMRT With Concurrent Cisplatin and Etoposide for Limited Disease SCLC Baosheng Li.

James D. Bearden, III, MD, FACP Principle Investigator Gibbs Cancer Center, Spartanburg, SC Gibbs Cancer Center Our NCCCP Journey 1.

Phase 2 study of the mTOR inhibitor RAD001 (everolimus) in combination with bevacizumab (avastin) in patients with sporadic and neurofibromatosis type.

The Use of Lay Patient Navigators to Improve Quality of Care and Accrual to Clinical Trials for Radiation Oncology Patients who are Minorities or of Low.

Title: Stereotactic Ablative Radiotherapy (SABR) can be Safe and Effective for Treatment of Central and Ultra-Central Lung Tumors. Author: Aadel Chaudhuri,

CDRP Program Steering Committee Dwight E. Heron, MD UPMC McKeesport February 2, 2007 Tampa, FL.

CDRP Steering Committee UPMC McKeesport January 20th, 2006.

The Inflammatory Breast Cancer Cancer Registry Paul H. Levine, M.D. Paul H. Levine, M.D. The George Washington University School of Public Health and Health.

Dana-Farber Cancer Institute (DFCI) and Prostate Health Education Network (PHEN) Partnership to Eliminate Prostate Cancer Disparities Edward J. Benz, Jr.,

Medicaid and the 4 A’s: Use of 1115 Waivers and State Plan Amendments American Cancer Society Washington, Dc June 5, 2008 Erin Reidy

Improving Cancer Outcomes for African-Americans New Hanover Regional Medical Center Coastal Area Health Education Center University of North Carolina at.

CDRP Program Update UPMC McKeesport Program Steering Committee RTOG Meeting Toronto, Canada June 23 rd, 2006.

PRO-CTCAE Face-To-Face Meeting #2 Advancing the Science of Adverse Symptom Monitoring in Cancer Treatment Trials Ethan Basch, M.D. Memorial Sloan-Kettering.

Promoting Patient Involvement in Medication Decisions David H. Hickam, MD, MPH Professor, Dept. of Medicine Oregon Health & Science University Portland,

Debra Freeman, MD – Naples Christopher King, MD, PhD - Stanford.

Ο ρόλος των μη χειρουργικών θεραπειών στο μη μεταστατικό μυοδιηθητικό καρκίνο ουροδόχου κύστεως Γεώργιος Δ. Λύπας Παθολόγος Ογκολόγος Α’ Ογκολογική Κλινική.

Radiation therapy for Early Stage Prostate Cancer

Treatment options for HPV+ disease

Treatment With Continuous, Hyperfractionated, Accelerated Radiotherapy (CHART) For Non-Small Cell Lung Cancer (NSCLC): The Weston Park Hospital Experience.

Factors Influencing Prostate Cancer Treatment Decisions for African American and White Men: Prostate Cancer Follow Back Study Keith Elder, MPA,MPH, PhD.

Evaluation of biologically equivalent dose escalation, clinical outcome, and toxicity in prostate cancer radiotherapy: A meta-analysis of 12,000 patients.

[ADD OTHER GRANTS AS NECESSARY]

What is the optimal pre-op therapy for esophagus and GE junction cancers?

New developments in oncological treatment for Stage 3 NSCLC

Palliative Thoracic Radiation Therapy for Non-Small Cell Lung Cancer: An Update of an ASTRO Evidence-Based Guideline Endorsed by the European Society.

Radiation Therapy for Prostate Cancer

[ADD OTHER GRANTS AS NECESSARY]

Disparities in Serious Illness Care for African Americans

“Managing Prostate Cancer Survivorship”

Megan Eguchi, MPh Sana karam, md, phd

Observations from the Rapporteurs

Receipt of Adjuvant Endometrial Cancer Treatment According to Race NRG Oncology/Gynecologic Oncology Group (GOG) 210 Study Ashley Felix, PhD, MPH Assistant.

Presentation transcript:

Improving Cancer Outcomes for African Americans Update for RTOG in Tampa Feb 2, 2007 Patrick D. Maguire, MD New Hanover Regional (NHRMC)

Update for NHRMC Feb 2, 2007 I.Radiotherapy (RT) Clinical Trials II. Publications III.Partnership & Telesynergy IV.Patient Navigation & Outreach

RT Clinical Trials at NHRMC CALGB – NSCLC RTOG 0214 – PCI, Advanced NSCLC RTOG 9804 – Good Risk DCIS (closed) NSABP-B35 – Tam vs. AI, DCIS (closed) CALGB – B + EB, Prostate (closed) RTOG 0232 – B + EB, Prostate RTOG 9811 – Anus (closed)

RT Clinical Trials at NHMRC S – screened & eligible E – enrolled U – underserved (AA &/or poor)

RT Clinical Trials Accrual 2006 TrialSEU NSCLC830 PCI, NSCLC50(2 pend) 0 DCIS, DCIS, B3592 1

RT Clinical Trials Accrual 2006 TrialSE U Prostate, (2pend)1 H&N, Z

RT Clinical Trial Accrual SEU Total

Publications: Manuscripts Maguire, Meyerson, Neal, et al, Toxic Cure: hyperfractionated radiotherapy with concurrent cisplatin and fluorouracil for stage III and IVa head and neck cancer in the community. IJROBP 58: , Hamann, Kotwall, & Maguire, The role of an AHEC in developing a model program to reduce cancer disparities. National AHEC Bulletin XXI: 39-40, Johnson, Race, health, and anti-white prejudice: the influence of chronic and temporary accessibility of anti-white stereotypes on black healthcare responses. J Person Soc Psych, manuscript under review. Hamann & Bost, Black-white differences in the influence of cancer experiences on religious beliefs and healthcare satisfaction. Manuscript in preparation.

Publications: Abstracts Hamann, Maguire, Bost, et al. Interactions of race, cancer knowledge and beliefs, religious beliefs, and perceived racism an cancer treatment decisions. ASTRO, Denver, 10/05 Hamann, Bost, Johnson, et al. Measuring the influence of cultural and social factors on cancer treatment decisions. Am Eval Assoc, Toronto, 10/05 Bost & Hamann. Effects of cancer on cultural and social beliefs. Intercultural Cancer Council, Washington DC, 4/06 Maguire & Rosenman. Bridging academic and community radiation oncology treatment planning. Am Telemed Assoc, San Diego, 5/06 Maguire & Honaker. A Year of Telesynergy in Southeastern North Carolina. Am Telemed Assoc, San Diego, 5/06.

Publications: Abstracts Hamann MS, Johnson J, Maguire PD, Effects of Cancer on Cultural Beliefs. ASTRO, Philadelphia, 10/06 Maguire PD, Neal CR, Menon RP, et al. Prostate Cancer in Southeastern North Carolina: It’s Not All Black & White. ASTRO, Philadelphia, 10/06

Partnership with UNC-CH & Telesynergy Relationship solid; visits Q4-6 months Telesynergy IMRT planning (infrequent) H&N Tumor Board -Qwk ZCC Trial – complete soon! Cyberknife – trials??

Patient Navigation & Outreach 2006 Navigator - LaSonia Melvin Asst Navigator – Ursula Wilson Patients Navigated: 2006 = 78 Total = 126 Outreach Sessions: 2006 = 28 Total = 53